-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation